MedPath

青岛黄海制药有限责任公司

Ownership
-
Established
1982-02-10
Employees
-
Market Cap
-
Website
https://www.qdhuanghai.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

125

NMPA:125

Drug Approvals

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20254533
Approval Date
Jun 10, 2025
NMPA

Ibuprofen Suspension

Product Name
布洛芬混悬液
Approval Number
国药准字H20254482
Approval Date
Jun 10, 2025
NMPA

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20254531
Approval Date
Jun 10, 2025
NMPA

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20254532
Approval Date
Jun 10, 2025
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20249750
Approval Date
Dec 17, 2024
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20249749
Approval Date
Dec 17, 2024
NMPA

Nifedipine Controlled-release Tablets

Product Name
硝苯地平控释片
Approval Number
国药准字H20249162
Approval Date
Oct 22, 2024
NMPA

Empagliflozin Tablets

Product Name
恩格列净片
Approval Number
国药准字H20234685
Approval Date
Dec 26, 2023
NMPA

Empagliflozin Tablets

Product Name
恩格列净片
Approval Number
国药准字H20234686
Approval Date
Dec 26, 2023
NMPA

Sildenafil Citrate Orodispersible Tablets

Product Name
枸橼酸西地那非口崩片
Approval Number
国药准字H20234296
Approval Date
Oct 18, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.